Harrow , a leading North American eyecare pharmaceutical company, announced the execution of a five-year strategic supply and development ("SSD") agreement for TRIESENCE® (triamcinolone acetonide ...

ABSTRACT: The rapid development of artificial intelligence (AI) technology is profoundly reshaping all walks of life, especially in the medical field. AI provides innovative tools for medical ...